Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$10.12 - $14.07 $7,822 - $10,876
773 Added 3.31%
24,100 $273,000
Q2 2021

Aug 16, 2021

SELL
$8.0 - $9.75 $978,240 - $1.19 Million
-122,280 Reduced 83.98%
23,327 $189,000
Q1 2021

May 17, 2021

SELL
$8.63 - $10.94 $150,999 - $191,417
-17,497 Reduced 10.73%
145,607 $1.35 Million
Q4 2020

Feb 16, 2021

BUY
$8.3 - $13.59 $1.21 Million - $1.98 Million
145,709 Added 837.65%
163,104 $1.58 Million
Q2 2020

Aug 14, 2020

SELL
$9.52 - $15.98 $43,487 - $72,996
-4,568 Reduced 20.8%
17,395 $226,000
Q1 2020

May 15, 2020

BUY
$8.0 - $15.48 $8,992 - $17,399
1,124 Added 5.39%
21,963 $223,000
Q4 2019

Feb 14, 2020

BUY
$14.82 - $26.79 $75,389 - $136,280
5,087 Added 32.29%
20,839 $326,000
Q3 2019

Nov 14, 2019

BUY
$16.02 - $22.47 $252,347 - $353,947
15,752 New
15,752 $264,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $80.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.